micro News and Research

RSS

CTS awarded new development and production program for piezoelectric micro actuators

CTS Corporation today announced that CTS Electronic Components was awarded a major new development and production program for piezoelectric micro actuators for data storage devices (hard disk drives). Production is anticipated to begin in the fourth quarter 2010 with total revenues over the next three years to be approximately $14 million and over $10 - $12 million annually thereafter.

18 Dec 2009

FDA grants marketing approval for EnzySurge's new SilverStream solution for prescription use

EnzySurge Ltd. (EnzySurge), a provider of innovative solutions for the advanced chronic wound management market, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its new SilverStream(TM) solution for prescription use. The FDA also cleared DermaSept, an Over-the-Counter version of the SilverStream product.

15 Dec 2009

FY2010 State and Foreign Ops bill expected to move on the Hill this month

The fiscal year 2010 State and Foreign Operations Appropriations bill, which includes funding for global health-related measures, "is moving on the Hill as part of a mammoth catch-all spending bill that's expected to move through both chambers this month," Foreign Policy's blog, "The Cable," reports. "

10 Dec 2009

Cell transplants may yield new therapies for dementia patients

Nerve cells transplanted into brain-damaged rats helped them to fully recover their ability to learn and remember, probably by promoting nurturing, protective growth factors, according to a new study.

10 Dec 2009

Researchers investigate bone pathology

The best way to prevent a fracture is to stop bones from reaching the point where they are prone to breaking, but understanding the process of how bones form and mature has been challenging. Now researchers at the University of Houston department of health and human performance have created a process that grows real human bone in tissue culture, which can be used to investigate how bones form and grow.

10 Dec 2009

Texas Sinus Center offers FinESS Sinus Treatment to break the cycle of chronic sinusitis

Dr. James Atkins, founder of the Texas Sinus Center (www.texassinuscenter.com), today announced he is now offering the FinESS® Sinus Treatment, a minimally invasive treatment that breaks the cycle of chronic sinusitis (CRS) at Foundation Surgical Hospital of San Antonio.

8 Dec 2009

Study: Genetic variations in miRNA pathway may be used to predict secondary tumor in head and neck cancer patients

Eighteen single-point genetic variations indicate risk of recurrence for early-stage head and neck cancer patients and their likelihood of developing a second type of cancer, researchers at The University of Texas M. D. Anderson Cancer Center reported at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference.

8 Dec 2009

New study reveals RNA may play a critical role in cancer treatment

Researchers from Yale University and Mirna Therapeutics, Inc., reversed the growth of lung tumors in mice using a naturally occurring tumor suppressor microRNA. The study reveals that a tiny bit of RNA may one day play a big role in cancer treatment, and provides hope for future patients battling one of the most prevalent and difficult to treat cancers.

7 Dec 2009

UniCare Health Plan and Cross Lanes Walmart organize food drive to assist poor families

UniCare Health Plan of West Virginia, Inc., Cross Lanes Walmart and West Virginia Radio Corporation will be holding the second-annual Circle of Hope for Charleston-based Mountain Mission. Several local celebrities, including 2006 World's Strongest Man Phil Pfister, Pro Bass Fisherman Jeremy Starks, Secretary of State Natalie Tenant, and Governor and Mrs. Manchin will participate in the two-day food drive.

5 Dec 2009

ACAMP hosts health and medical seminar

Today ACAMP hosted a health & medical seminar, explaining how technologies like nanotechnology, biomaterials and microfluidics can play a powerful role in the creation of innovative healthcare products that help promote health and improve the quality, cost and outcomes of patient care, while opening new markets for Alberta companies worldwide.

4 Dec 2009

Silicon to transport drugs in the human body: a novel drug delivery method under development

Several Finnish universities have joined forces to develop an innovative drug delivery method that utilises silicon to transport drugs in the human body. Among other advances, the project has been able to sustain the effect of peptides controlling appetite, which may facilitate the use of nanotechnology for dieting purposes. The research is being carried out as part of the Academy of Finland's Research Programme on Nanoscience (FinNano).

4 Dec 2009

FDA approves St. Jude Medical's Penta surgical lead for neurostimulation therapy

St. Jude Medical, Inc. today announced the U.S. Food and Drug Administration (FDA) approval and U.S. market introduction of its new Penta™ surgical lead for neurostimulation therapy. Unveiled at the annual North American Neuromodulation Society meeting, the Penta lead is the first of its kind, featuring the smallest electrodes in the market arranged in five columns.

4 Dec 2009

Presbia's Flexivue lens obtains CE certification

Presbia, a leader in the development and marketing of a surgical solution for presbyopia, today announced its Flexivue™ micro-lens received CE certification for its products sold within the European Economic Area (EEA). Specifically, the CE mark certifies that Flexivue™ has met European Union consumer safety, health and environmental requirements.

4 Dec 2009

NHLBI awards new federal grant to improve the quality of stored transfusion blood

A new, $2.8 million, four-year federal grant will support researchers at the University of Pittsburgh School of Medicine and their collaborators at Wake Forest University as they study why the quality of stored transfusion blood degrades over time and how to address the problem.

3 Dec 2009

Pycnogenol can improve microcirculation, retinal edema and visual acuity, reveals study

According to the National Institute of Health, 40 percent to 45 percent of Americans diagnosed with diabetes already have some stage of diabetic retinopathy.

2 Dec 2009

New study indicates pine bark may reduce progressing advanced stages of diabetic retinopathy

According to the National Institute of Health, 40 percent to 45 percent of Americans diagnosed with diabetes already have some stage of diabetic retinopathy. Diabetic retinopathy, damage to the retina caused by leaky blood vessels, is a major cause of blindness in people with diabetes and is one of the most feared diabetic complications. In

2 Dec 2009

SinoFresh Healthcare re-launches sales and distribution of Sinofresh Nasal Spray

SinoFresh Healthcare, Inc. over the last six months has re-launched sales and distribution of the Sinofresh Nasal Spray product through the exclusive licensee of the products through, Sinofresh Healthcare Products, Inc., a privately held company.

2 Dec 2009

New patented technology to combat healthcare-associated infections

Independent testing performed at ATS Labs, an internationally recognized antimicrobial testing laboratory, demonstrated that PerfectClean with Micrillon wipers eliminated biological contaminants in a very short time. This promising technology has the potential to impact disinfection practices in the healthcare market.

2 Dec 2009

Optoacoustics' FOMRI-III optical microphone now available for use in fMRI environments

Optoacoustics has announced availability of the FOMRI-III(TM) dual channel microphone, the most advanced optical microphone available for use in functional magnetic resonance imaging (fMRI) environments.

1 Dec 2009

Shanghai Biolaxy receives IND approval for insulin formulation to treat diabetes

Shanghai Biolaxy announced the Chinese State Food & Drug Administration (SFDA) has approved the investigational new drug application (IND) for its oral insulin project (Nodlin), an innovative insulin formulation to treat diabetes. This IND approval allows Biolaxy to initiate its first phase I clinical study.

24 Nov 2009

micro News and Research

CTS awarded new development and production program for piezoelectric micro actuators

FDA grants marketing approval for EnzySurge's new SilverStream solution for prescription use

FY2010 State and Foreign Ops bill expected to move on the Hill this month

Cell transplants may yield new therapies for dementia patients

Researchers investigate bone pathology

Texas Sinus Center offers FinESS Sinus Treatment to break the cycle of chronic sinusitis

Study: Genetic variations in miRNA pathway may be used to predict secondary tumor in head and neck cancer patients

New study reveals RNA may play a critical role in cancer treatment

UniCare Health Plan and Cross Lanes Walmart organize food drive to assist poor families

ACAMP hosts health and medical seminar

Silicon to transport drugs in the human body: a novel drug delivery method under development

FDA approves St. Jude Medical's Penta surgical lead for neurostimulation therapy

Presbia's Flexivue lens obtains CE certification

NHLBI awards new federal grant to improve the quality of stored transfusion blood

Pycnogenol can improve microcirculation, retinal edema and visual acuity, reveals study

New study indicates pine bark may reduce progressing advanced stages of diabetic retinopathy

SinoFresh Healthcare re-launches sales and distribution of Sinofresh Nasal Spray

New patented technology to combat healthcare-associated infections

Optoacoustics' FOMRI-III optical microphone now available for use in fMRI environments

Shanghai Biolaxy receives IND approval for insulin formulation to treat diabetes

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News